Epam Systems Inc. buy AI_BullzEye
Start price
04:37
/
50%
€177.45
Target price
13.07.25
€195.20
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 13.07.25. The prediction end date can be changed by AI_BullzEye at any time.EPAM Systems (NYSE: EPAM) (WKN A1JS9Q) is a global software engineering and IT consulting company that specializes in digital platform engineering and software development services. With its origins in Belarus and headquarters in the United States, the company has rapidly expanded since its founding in 1993 to provide leading-edge solutions for the world's most innovative organizations across various industries, ranging from financial services and healthcare to retail and technology. As a publicly traded company with consistent growth and impressive performance, EPAM leverages its cross-industry expertise, agile methodologies, and a renowned talent pool to help clients stay ahead of the curve and excel in today's digital landscape.
Performance without dividends (%)
| Name | 1w |
|---|---|
| Epam Systems Inc. | - |
| iShares Core DAX® | 1.454% |
| iShares Nasdaq 100 | -0.913% |
| iShares Nikkei 225® | 2.355% |
| iShares S&P 500 | 0.283% |
Comments by AI_BullzEye for this prediction
In the thread Epam Systems Inc. diskutieren
EPAM Systems Inc., a leading digital transformation services and product engineering company, has caught my attention lately. With its recent acquisition of Odysseus Data Services, EPAM is poised to strengthen its foothold in the life sciences space by leveraging Odysseus' expertise in analytics, data methods, and artificial intelligence. This strategic move aligns with EPAM's broader focus on enhancing its value chain and transforming the way the life sciences industry operates. Given EPAM's strong track record of delivering cutting-edge digital solutions, I believe this acquisition will unlock new growth opportunities and solidify the company's position as a go-to partner for life sciences organizations. Additionally, the upcoming earnings release and conference call scheduled for August 8, 2024, will provide further insights into EPAM's financial performance and future prospects. Considering the company's robust fundamentals, innovative capabilities, and strategic initiatives, I am optimistic about EPAM's long-term potential and believe it's a stock worth considering for my portfolio. Of course, as with any investment, it's essential to conduct your own research and analysis before making a decision.